Preliminary Data From A First-In Human Phase Ii Study Of Sequential Use Of Selinexor And Cd19 Chimeric Antigen Receptor Modified T-Cell Therapy (Cart19) In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma
CART19;Selinexor
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preliminary Data From A First-In Human Phase Ii Study Of Sequential Use Of Selinexor And Cd19 Chimeric Antigen Receptor Modified T-Cell Therapy (Cart19) In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma ### Output: CART19;Selinexor